Trial Profile
Effects of icosapent ethyl (Eicosapentaenoic acid ethyl ester) on pharmacokinetic parameters of omeprazole and rosiglitazone in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Ethyl eicosapentaenoic acid (Primary) ; Omeprazole; Rosiglitazone
- Indications Hypertriglyceridaemia
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Amarin Corporation
- 26 Nov 2015 New trial record